Fairvalue-Calculator Fairvalue-Calculator
EN DE

Scandinavian Real Heart AB (HEART) Fair Value & Analysis

Healthcare · SE · Market cap 180M SEK

Pricekr 22.90
Fair Valuekr 33.09
Upside+44.5%
Quality95/100
Evidence: Low Range kr 24.82 – kr 41.37

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Scandinavian Real Heart AB (HEART) currently trades at kr 22.90, while our model-based Fair Value estimate is kr 33.09 — implying the stock looks roughly 44.5% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is Scandinavian Real Heart AB (HEART) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 33.09 versus a price of kr 22.90 — about +44% (undervalued). Model-based estimate, not financial advice.
What is the fair value of HEART?
Our 21-model fair value for Scandinavian Real Heart AB is kr 33.09 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 22.90.
What is the quality score of HEART?
Scandinavian Real Heart AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.